Trillium Therapeutics shares soar on Pfizer’s $2.26B deal
Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
via DigioNews Markets
Note : I Hope My My New News Article : Trillium Therapeutics shares soar on Pfizer’s $2.26B deal Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Trillium Therapeutics shares soar on Pfizer’s $2.26B deal
0 Comments